JP2020500903A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020500903A5 JP2020500903A5 JP2019530645A JP2019530645A JP2020500903A5 JP 2020500903 A5 JP2020500903 A5 JP 2020500903A5 JP 2019530645 A JP2019530645 A JP 2019530645A JP 2019530645 A JP2019530645 A JP 2019530645A JP 2020500903 A5 JP2020500903 A5 JP 2020500903A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- cell according
- pharmaceutical composition
- receptor
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023027231A JP2023078149A (ja) | 2016-12-09 | 2023-02-24 | キメラクロロトキシン受容体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662432404P | 2016-12-09 | 2016-12-09 | |
| US62/432,404 | 2016-12-09 | ||
| PCT/US2017/065488 WO2018107134A1 (en) | 2016-12-09 | 2017-12-09 | Chimeric chlorotoxin receptors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023027231A Division JP2023078149A (ja) | 2016-12-09 | 2023-02-24 | キメラクロロトキシン受容体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020500903A JP2020500903A (ja) | 2020-01-16 |
| JP2020500903A5 true JP2020500903A5 (enExample) | 2021-01-28 |
Family
ID=62491409
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019530645A Pending JP2020500903A (ja) | 2016-12-09 | 2017-12-09 | キメラクロロトキシン受容体 |
| JP2023027231A Pending JP2023078149A (ja) | 2016-12-09 | 2023-02-24 | キメラクロロトキシン受容体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023027231A Pending JP2023078149A (ja) | 2016-12-09 | 2023-02-24 | キメラクロロトキシン受容体 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US11421005B2 (enExample) |
| EP (1) | EP3551657B1 (enExample) |
| JP (2) | JP2020500903A (enExample) |
| KR (2) | KR102618373B1 (enExample) |
| CN (1) | CN110352197B (enExample) |
| AU (1) | AU2017371329B2 (enExample) |
| CA (1) | CA3044393A1 (enExample) |
| IL (1) | IL266950B2 (enExample) |
| WO (1) | WO2018107134A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12005078B2 (en) | 2015-09-03 | 2024-06-11 | The Uab Research Foundation | Genetically engineered drug resistant T cells and methods of using the same |
| CA3044393A1 (en) | 2016-12-09 | 2018-06-14 | The Uab Research Foundation | Chimeric chlorotoxin receptors |
| US20230374085A1 (en) * | 2020-03-11 | 2023-11-23 | City Of Hope | Dual-targeting chimeric antigen receptor modified t cells comprising il-13 and chlorotoxin for cancer treatment |
| WO2021190551A1 (zh) * | 2020-03-25 | 2021-09-30 | 上海先博生物科技有限公司 | 结合cd19的嵌合抗原受体及其用途 |
| US20240115717A1 (en) * | 2020-12-30 | 2024-04-11 | Vrg Therapeutics Kft. | Chlorotoxin derivatives and use thereof |
| CN117202913A (zh) * | 2021-01-20 | 2023-12-08 | 因8生物公司 | 多价氯毒素嵌合抗原受体 |
| KR20230134134A (ko) * | 2021-01-20 | 2023-09-20 | 인8바이오 인코포레이티드 | 다가 클로로톡신 키메라 항원 수용체 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5892019A (en) | 1987-07-15 | 1999-04-06 | The United States Of America, As Represented By The Department Of Health And Human Services | Production of a single-gene-encoded immunoglobulin |
| PE20081140A1 (es) | 2006-10-25 | 2008-09-22 | Amgen Inc | Agentes terapeuticos a base de peptidos derivados de toxinas |
| EP2173385A1 (en) * | 2007-08-07 | 2010-04-14 | Transmolecular, Inc. | Chlorotoxins as drug carriers |
| CA2735456C (en) * | 2008-08-26 | 2021-11-16 | City Of Hope | Method and compositions for enhanced anti-tumor effector functioning of t cells |
| DK3246042T3 (da) * | 2009-11-02 | 2019-10-14 | Univ Emory | Lægemiddelresistent immunterapi til behandling af cancer |
| JP5858932B2 (ja) * | 2010-02-04 | 2016-02-10 | モルフォテック， インコーポレイテッド | クロロトキシンポリペプチドおよびコンジュゲートならびにその使用 |
| HK1220614A1 (zh) * | 2013-03-10 | 2017-05-12 | Baylor College Of Medicine | 耐化疗免疫细胞 |
| WO2015031645A1 (en) | 2013-08-28 | 2015-03-05 | Washington University | Monoclonal antibodies to human 14-3-3 epsilon and human 14-3-3 epsilon sv |
| GB201506423D0 (en) | 2015-04-15 | 2015-05-27 | Tc Biopharm Ltd | Gamma delta T cells and uses thereof |
| JP7105188B2 (ja) | 2015-08-25 | 2022-07-22 | ザ・ユー・エイ・ビー・リサーチ・フアンデーシヨン | 幹細胞移植方法 |
| US12005078B2 (en) * | 2015-09-03 | 2024-06-11 | The Uab Research Foundation | Genetically engineered drug resistant T cells and methods of using the same |
| JP7085990B2 (ja) * | 2015-10-13 | 2022-06-17 | シティ・オブ・ホープ | クロロトキシンドメインを含むキメラ抗原レセプター |
| CA3044393A1 (en) | 2016-12-09 | 2018-06-14 | The Uab Research Foundation | Chimeric chlorotoxin receptors |
-
2017
- 2017-12-09 CA CA3044393A patent/CA3044393A1/en active Pending
- 2017-12-09 IL IL266950A patent/IL266950B2/en unknown
- 2017-12-09 EP EP17877604.3A patent/EP3551657B1/en active Active
- 2017-12-09 CN CN201780075849.7A patent/CN110352197B/zh not_active Expired - Fee Related
- 2017-12-09 US US16/467,467 patent/US11421005B2/en active Active
- 2017-12-09 KR KR1020197016382A patent/KR102618373B1/ko active Active
- 2017-12-09 KR KR1020237044314A patent/KR20240005979A/ko not_active Ceased
- 2017-12-09 AU AU2017371329A patent/AU2017371329B2/en not_active Expired - Fee Related
- 2017-12-09 WO PCT/US2017/065488 patent/WO2018107134A1/en not_active Ceased
- 2017-12-09 JP JP2019530645A patent/JP2020500903A/ja active Pending
-
2022
- 2022-07-14 US US17/864,935 patent/US20230037076A1/en not_active Abandoned
-
2023
- 2023-02-24 JP JP2023027231A patent/JP2023078149A/ja active Pending
-
2025
- 2025-12-02 US US19/405,783 patent/US20260176311A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025032091A5 (enExample) | ||
| IL266950B2 (en) | ?? ? cells that express chimeric antigen receptor for use in immunotherapy | |
| RU2017105160A (ru) | Лечение рака с помощью химерного антигенного рецептора к cd33 | |
| JP2021000103A5 (enExample) | ||
| JP2020533958A5 (enExample) | ||
| JP2019523301A5 (enExample) | ||
| JP2018538339A5 (enExample) | ||
| JP2017522879A5 (enExample) | ||
| JP2022501043A5 (enExample) | ||
| RU2017105161A (ru) | Лечение рака с использованием химерного антигенного рецептора cll-1 | |
| JP2021500881A5 (enExample) | ||
| RU2017105065A (ru) | Лечение злокачественного новообразования с использованием гуманизированного химерного антигенного рецептора против всма | |
| JP2022523781A5 (enExample) | ||
| JP2019515661A5 (enExample) | ||
| RU2017108903A (ru) | Химерный антигенный рецептор (car) против cd123 для использования в лечении злокачественных опухолей | |
| FI3844267T3 (fi) | Menetelmät kimeeristä antigeenireseptoria ilmentävien solujen valmistamiseksi | |
| JP2021520788A5 (enExample) | ||
| JP2020513839A5 (enExample) | ||
| HRP20221348T1 (hr) | Kimerni receptori i postupci njihove uporabe | |
| JP2020517295A5 (enExample) | ||
| JP2019516352A5 (enExample) | ||
| JP2017522880A5 (enExample) | ||
| JP2024527557A5 (enExample) | ||
| JP2017527271A5 (enExample) | ||
| JP2017530694A5 (enExample) |